Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.16.3.1 (
ceruloplasmin
)
5,074
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The comparison of protective effects of native
ceruloplasmin
(CP) and of preparation CP1 containing carbohydrate fragment GlcNAc(beta(1,4]GlcNAc which specifically binds on RBC (alpha(1,6)Fuc receptors showed that CP1 exhibits much more powerful protective effect on RBC in copper-induced lysis. It was found, however, that
CP2
(native CP devoided of CP1) protected RBC as well as CP despite its inability of binding to RBC membrane. CP and CP1 in a similar way decrease copper concentration in RBC. It was shown that copper accumulation and GSH decrease in RBC are two independent and concurrent processes; the copper and GSH concentrations are not the factors determining RBC resistance to hemolysis. CP inhibits the reaction of superoxide radicals generation as a result of Cu interaction with -SH groups of RBC membrane; the effect is more pronounced than the effect of catalase or superoxide dismutase. CP and CP1 preparations equally inhibit this reaction. Apparently CP reception on RBC leads not only to membrane protection from superoxide and hydroxyl radicals but represents a more complex process.
...
PMID:The protective effect of different forms of human ceruloplasmin in copper-induced lysis of red blood cells. 228 81
Ceruloplasmin (CP) is the major plasma antioxidant and copper transport protein. Monoclonal antibodies (mAbs) against human CP were produced and characterized. A total of five hybridoma cell lines were established (
CP2
, CP10, CP20, CP25, CP30). From the epitope mapping analysis, two subgroups of mAbs recognize different peptide fragments were identified. When the purified CP was incubated with the mAbs, the
ferroxidase
activity of CP was inhibited up to a maximum 57 %. Immunoblotting with various tissue homogenates indicated that all the mAbs specifically recognize a single protein band of 130 kDa. They also appear to be extensively cross-reactive among different mammalian including human and avian sources. These results demonstrated that only one type of immunologically similar CP is present in all of the mammalian tissues including human. The CP mAbs could be of great benefit to design the diagnostic kit for CP-related diseases such as Wilson's disease.
...
PMID:Production and characterization of monoclonal antibodies against human ceruloplasmin. 1571 49